Skip to main content
. 2023 Aug 2;43(8):426–449. doi: 10.1080/10985549.2023.2229225

FIG 1.

FIG 1

ATF3 is a p53 target gene that is activated via the ISR in a p53-independent manner. Western blot analysis of (A) ATF3 and (B) p53 with GAPDH as a loading control in HCT116 p53 WT (left) and p53 null cells (right) following a 6 h treatment with DMSO, 5 μM Nutlin-3A (NUT), 100 μM etoposide (ETOP), 2 μM tunicamycin (TM) or 2 mM histidinol (HisOH). Gene expression analysis of the (C) ATF3 gene (D) CDKN1A gene and (E) ASNS gene in HCT116 p53 WT (black) and HCT116 p53 null (pink) cells in response to 6 h treatment with stimuli. All statistical comparisons were computed using a one-way ANOVA test. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.